Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -96.08% | -319.85% | -97.98% | -58.93% | 55.85% |
| Total Depreciation and Amortization | -18.92% | -6.62% | 0.07% | 1.75% | 1.09% |
| Total Amortization of Deferred Charges | 36.98% | -79.26% | -89.25% | -92.53% | -95.69% |
| Total Other Non-Cash Items | 104.91% | 107.11% | 88.32% | 76.98% | -215.91% |
| Change in Net Operating Assets | -64.84% | -41.74% | -19.86% | -29.29% | -205.98% |
| Cash from Operations | -24.96% | -37.97% | -34.14% | -58.93% | -138.85% |
| Capital Expenditure | -129.61% | 83.19% | 75.09% | 87.50% | 129.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -129.61% | 83.19% | 75.09% | 87.50% | 129.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.53% | -61.48% | -61.61% | -99.94% | 6,950.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 99.94% | 100.00% | 82.56% | -- |
| Cash from Financing | -33.33% | -33.34% | -33.53% | -110.74% | 3,968.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.04% | -226.39% | -173.85% | -274.65% | 175.12% |
